{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,22]],"date-time":"2026-11-22T03:25:05Z","timestamp":1795317905483,"version":"4.10.3"},"reference-count":21,"publisher":"Elsevier BV","issue":"35","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T00:00:00Z","timestamp":1625443200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1131495"],"award-info":[{"award-number":["OPP1131495"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1154700"],"award-info":[{"award-number":["OPP1154700"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BBS\/E\/I\/00007039"],"award-info":[{"award-number":["BBS\/E\/I\/00007039"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.vaccine.2021.07.001","type":"journal-article","created":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T09:46:55Z","timestamp":1626860815000},"page":"5015-5024","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["The selection of naturally stable candidate foot-and-mouth disease virus vaccine strains for East Africa"],"prefix":"10.1016","volume":"39","author":[{"given":"Ben","family":"Jackson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjie","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Perez-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginette","family":"Wilsden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Juleff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Charleston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Seago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.07.001_b0005","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1128\/CMR.17.2.465-493.2004","article-title":"Foot-and-mouth disease","volume":"17","author":"Grubman","year":"2004","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2021.07.001_b0010","doi-asserted-by":"crossref","first-page":"6842","DOI":"10.1016\/j.vaccine.2017.10.040","article-title":"Genetic and antigenic characterization of serotype O FMD viruses from East Africa for the selection of suitable vaccine strain","volume":"35","author":"Lloyd-Jones","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.07.001_b0015","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.meegid.2010.06.017","article-title":"Diversity and transboundary mobility of serotype O foot-and-mouth disease virus in East Africa: implications for vaccination policies","volume":"10","author":"Balinda","year":"2010","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.vaccine.2021.07.001_b0020","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1099\/jgv.0.000462","article-title":"Application of the thermofluor PaSTRy technique for improving foot-and-mouth disease virus vaccine formulation","volume":"97","author":"Kotecha","year":"2016","journal-title":"J General Virol"},{"key":"10.1016\/j.vaccine.2021.07.001_b0025","unstructured":"OIE. Foot-and-Mouth Disease, Manual of Diagnostic Tests and Vaccines for Terrestrial Animals: Mammals, Birds, and Bees. Paris; 2012."},{"key":"10.1016\/j.vaccine.2021.07.001_b0030","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0034-5288(18)33445-3","article-title":"Radial immuno-diffusion and serum-neutralisation techniques for the assay of antibodies to swine vesicular disease","volume":"20","author":"Golding","year":"1976","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2021.07.001_b0035","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/BF01863914","article-title":"Beitrag zur kollektiven behandlung pharmakologischer reihenversuche","volume":"162","author":"K\u00e4rber","year":"1931","journal-title":"Archiv f experiment Pathol u Pharmakol"},{"key":"10.1016\/j.vaccine.2021.07.001_b0040","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1128\/JCM.00510-09","article-title":"Highly sensitive fetal goat tongue cell line for detection and isolation of foot-and-mouth disease virus","volume":"47","author":"Brehm","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2021.07.001_b0045","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/1991168a0","article-title":"Purification of radioactive foot-and-mouth disease virus","volume":"199","author":"Brown","year":"1963","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2021.07.001_b0050","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF01320790","article-title":"Thermal stability of foot-and-mouth disease virus","volume":"70","author":"Doel","year":"1981","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2021.07.001_b0055","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nsmb.3096","article-title":"Structure-based energetics of protein interfaces guides foot-and-mouth disease virus vaccine design","volume":"22","author":"Kotecha","year":"2015","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.vaccine.2021.07.001_b0060","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1016\/S0264-410X(03)00219-6","article-title":"Foot-and-mouth disease vaccine potency testing: determination and statistical validation of a model using a serological approach","volume":"21","author":"Barnett","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.07.001_b0065","doi-asserted-by":"crossref","first-page":"113786","DOI":"10.1016\/j.jviromet.2019.113786","article-title":"FMD vaccine matching: Inter laboratory study for improved understanding of r1 values","volume":"276","author":"Willems","year":"2020","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2021.07.001_b0070","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0092-1157(84)80013-X","article-title":"Antigenic variation in foot-and-mouth disease: studies based on the virus neutralization reaction","volume":"12","author":"Rweyemamu","year":"1984","journal-title":"J Biol Stand"},{"key":"10.1016\/j.vaccine.2021.07.001_b0075","doi-asserted-by":"crossref","first-page":"13654","DOI":"10.1038\/s41598-018-31856-x","article-title":"Chimeric O1K foot-and-mouth disease virus with SAT2 outer capsid as an FMD vaccine candidate","volume":"8","author":"Kotecha","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2021.07.001_b0080","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02312-16","article-title":"SAT2 foot-and-mouth disease virus structurally modified for increased thermostability","volume":"91","author":"Scott","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2021.07.001_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11262-019-01714-7","article-title":"Cell culture propagation of foot-and-mouth disease virus: adaptive amino acid substitutions in structural proteins and their functional implications","volume":"56","author":"Dill","year":"2020","journal-title":"Virus Genes"},{"key":"10.1016\/j.vaccine.2021.07.001_b0090","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1128\/JVI.77.5.3269-3280.2003","article-title":"Evaluation of genetically engineered derivatives of a Chinese strain of foot-and-mouth disease virus reveals a novel cell-binding site which functions in cell culture and in animals","volume":"77","author":"Zhao","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2021.07.001_b0095","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1099\/vir.0.071597-0","article-title":"Cell culture adaptation mutations in foot-and-mouth disease virus serotype A capsid proteins: implications for receptor interactions","volume":"96","author":"Mohapatra","year":"2015","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2021.07.001_b0100","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.virusres.2010.07.010","article-title":"Mapping of amino acid residues responsible for adhesion of cell culture-adapted foot-and-mouth disease SAT type viruses","volume":"153","author":"Maree","year":"2010","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2021.07.001_b0105","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.1128\/jvi.64.11.5519-5528.1990","article-title":"Unique amino acid substitutions in the capsid proteins of foot-and-mouth disease virus from a persistent infection in cell culture","volume":"64","author":"Diez","year":"1990","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21008604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21008604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:59:11Z","timestamp":1759402751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21008604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":21,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0264410X21008604"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.07.001","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The selection of naturally stable candidate foot-and-mouth disease virus vaccine strains for East Africa","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}